Guillain-Barré and Fisher syndromes: Update on the pathophysiological role of antiganglioside antibodies

Clinical Neurology

Volumn 52, Issue 11, 2012, Pages 914-916

  Kaida, Kenichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Antiganglioside antibody; Complement; Ganglioside complex; Glycolipid environment; Guillain Barr syndrome

Indexed keywords

CALCIUM CHANNEL; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1 ANTIBODY; GLYCOLIPID; LM1 ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; CELL MEMBRANE; COMPLEMENT ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; ENVIRONMENT; EX VIVO STUDY; GUILLAIN BARRE SYNDROME; MOUSE; NERVE; NERVE CELL; NERVE CELL MEMBRANE; NERVE ENDING; NERVE INJURY; NERVE MEMBRANE; NONHUMAN; PATHOPHYSIOLOGY; RESPIRATORY TRACT INFECTION;

AUTOANTIBODIES; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; MILLER FISHER SYNDROME;

EID: 84880531262     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.52.914     Document Type: Conference Paper

References (10)

1. Kaida K, Morita D, Kanzaki M, et al. Ganglioside complexes: as new target antigens in Guillain-Barré syndrome. Ann Neurol 2004;56:567-571.
2. Kaida K, Sonoo M, Ogawa G, et al. GMl/GalNAc-GDl a complex: a target for pure motor Guillain-Barré syndrome. Neurology 2008;71:1683-1690.
3. Kuwahara M, Suzuki S, Takada K, et al. Antibodies to LM 1 and LM 1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 2011;239:87-90.
4. Ogawa G, Kaida K, Kusunoki S, et al. Antibodies to ganglioside complexes consisting of asialo-GMl and GQlb or GTla in Fisher and Guillain-Barre syndromes. J Neuroimmunol 2009;214:125-127.
5. Susuki K, Rasband MN, Tohyama K, et al. Anti-GMl antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007;27:3956-3967.
6. Susuki K, Yuki N, Schafer DP, et al. Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibodymediated neuropathies. Exp Neurol 2012;233:534-542.
7. Zitman F M P, Greenshields KN, Kuijf ML, et al. Neuropathophysiological potential of Guillain-Barré syndrome.anti-ganglioside-complex antibodies at mouse motor nerve terminals. Clin Exp Neuroimmunol 2011;2:59-67.
8. Ueda A, Shima S, Miyashita T, et al. Anti-GMl antibodies affect the integrity of lipid rafts. Mol Cell Neurosci 2010;45:355-362.
9. Kaida K, Kamakura K, Ogawa G, et al. GDlb-specific antibody induces ataxia in Guillain-Barre syndrome. Neurology 2008;71:196-201.
10. Greenshields KN, Halstead SK, Zitman FM, et al. The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J Clin Invest 2009;119:595-610.